Value Health 2022 Jun 11;25(6):965-974. Epub 2022 Jan 11.
Health Technology Analysts, Sydney, New South Wales, Australia; The George Institute for Global Health, Sydney, New South Wales, Australia; The University of New South Wales, Sydney, New South Wales, Australia. Electronic address:
Objectives: Cutaneous T-cell lymphoma (CTCL) is a rare and incurable disease, and patients currently experience a lack of treatment options in Australia. This analysis evaluated the cost-effectiveness of extracorporeal photopheresis (ECP) compared with standard of care therapy for the treatment of patients with erythrodermic (stage T, M) CTCL, who are refractory to previous systemic treatment.
Methods: A Markov model was developed from the perspective of the Australian government. Read More